Objectives To describe the distributions of bedaquiline and linezolid MIC values for the Mycobacterium tuberculosis WT population and to define the corresponding epidemiological cut-offs (ECOFFs) in three Latin American countries. Methods MICs of bedaquiline and linezolid were determined by the resazurin microtitre assay (REMA). In phase 1, interlaboratory reproducibility was assessed using a panel of 10 fully susceptible M. tuberculosis strains. Phase 2 involved MIC determination for 248 clinical isolates from Argentina (n = 58), Brazil (n = 100) and Peru (n = 90) from patients who were treatment-naive for bedaquiline and linezolid. We then determined the ECOFFs for bedaquiline and linezolid by the eyeball method and the ECOFFinder statist...
Objectives: The aim of this study was to establish wild-type MIC distributions of first-line drugs f...
Criteria defining bedaquiline resistance for tuberculosis have been proposed addressing an emerging ...
Fil: de Kantor, Isabel N. Organización Panamericana de la Salud (OPS, OMS); Argentina.Fil: Latini, O...
To describe the distributions of bedaquiline and linezolid MIC values for the Mycobacterium tubercul...
Fil: López, Beatriz. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departame...
Bedaquiline (Sirturo) and delamanid (Deltyba) have recently been approved by the regulatory authorit...
Bedaquiline and delamanid have recently been approved by the regulatory authorities for treatment of...
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-resistant-tuberculosis (MDR-TB) (DREAM...
Drug susceptibility testing of M. tuberculosis is rooted in a binary susceptible/resistant paradigm....
Drug susceptibility testing of M. tuberculosis is rooted in a binary susceptible/resistant paradigm....
Aims: Bedaquiline is now recommended to all patients in the treatment of multidrug-resistant tubercu...
Bedaquiline (B), pretomanid (Pa) and linezolid (L) are key components of new regimens for treating r...
Drug-resistant tuberculosis persists as a major public health concern. Alongside efficacious treatme...
We report the range of minimum inhibitory concentrations for six antimicrobial drugs in 228 clinical...
Rationale: Bedaquiline has been classified as a group A drug for the treatment of multidrug-resistan...
Objectives: The aim of this study was to establish wild-type MIC distributions of first-line drugs f...
Criteria defining bedaquiline resistance for tuberculosis have been proposed addressing an emerging ...
Fil: de Kantor, Isabel N. Organización Panamericana de la Salud (OPS, OMS); Argentina.Fil: Latini, O...
To describe the distributions of bedaquiline and linezolid MIC values for the Mycobacterium tubercul...
Fil: López, Beatriz. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departame...
Bedaquiline (Sirturo) and delamanid (Deltyba) have recently been approved by the regulatory authorit...
Bedaquiline and delamanid have recently been approved by the regulatory authorities for treatment of...
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-resistant-tuberculosis (MDR-TB) (DREAM...
Drug susceptibility testing of M. tuberculosis is rooted in a binary susceptible/resistant paradigm....
Drug susceptibility testing of M. tuberculosis is rooted in a binary susceptible/resistant paradigm....
Aims: Bedaquiline is now recommended to all patients in the treatment of multidrug-resistant tubercu...
Bedaquiline (B), pretomanid (Pa) and linezolid (L) are key components of new regimens for treating r...
Drug-resistant tuberculosis persists as a major public health concern. Alongside efficacious treatme...
We report the range of minimum inhibitory concentrations for six antimicrobial drugs in 228 clinical...
Rationale: Bedaquiline has been classified as a group A drug for the treatment of multidrug-resistan...
Objectives: The aim of this study was to establish wild-type MIC distributions of first-line drugs f...
Criteria defining bedaquiline resistance for tuberculosis have been proposed addressing an emerging ...
Fil: de Kantor, Isabel N. Organización Panamericana de la Salud (OPS, OMS); Argentina.Fil: Latini, O...